AntibioticMech

novobiocin

CHEBI:28368 ·resolve ·ANTIBACTERIAL ·EXACT SEEDED

A coumarin-derived antibiotic obtained from Streptomyces niveus. — ChEBI

Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.

Classification

aminocoumarin antibioticARO:3000103

Strictly broader compounds or drug classes this molecule belongs to.

Chemical structure

Computed structure properties
Molecular formulaC31H36N2O11
Charge0
Average mass612.632 Da
Monoisotopic mass612.23191 Da
SourceChEBI
InChIKeyYJQPYGGHQPGBLI-KGSXXDOSSA-N

SMILES

CO[C@@H]1[C@@H](OC(N)=O)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C

InChI

InChI=1S/C31H36N2O11/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37)/t23-,25+,26-,29-/m1/s1

Also called

Cross-references

Equivalent identifiers for this same structure in other resources.

Activity roles

Every antimicrobial role a source asserts for this compound — the unreduced evidence behind its antimicrobial_class.

Source concepts

Every upstream concept that resolved to this record. The merge is the product: this is what shows ChEBI and CARD are describing the same structure.

Upstream concepts merged into this record
SourceNative IDLabelMinted CURIEVersion
ARO ARO:3000111 novobiocin antibioticmech:aro-de163f36e9 2026-08-30
CHEBI CHEBI:28368 novobiocin antibioticmech:chebi-e739e10a6f 2026-08-30

Molecular targets

The molecular entity or process this compound acts on. Each target carries evidence — this is a mechanistic claim, not a classification.

aminocoumarin sensitive parE PROTEIN DIRECT_BINDING_TARGET

ARO:3000023

CARD/ARO database assertion; target organism, strain, and assay are not specified. Topoisomerase IV subunit asserted as the aminocoumarin-sensitive target. Evidence status: PRIMARY_EVIDENCE_NEEDED. Source: CARD_ARO 2026-08-30 (retrieved 2026-08-30).

antibiotic sensitive DNA topoisomerase subunit gyrB PROTEIN DIRECT_BINDING_TARGET

ARO:3000734

CARD/ARO database assertion; target organism, strain, and assay are not specified. ARO explicitly describes ligand binding to gyrase subunit B. Evidence status: PRIMARY_EVIDENCE_NEEDED. Source: CARD_ARO 2026-08-30 (retrieved 2026-08-30).

aminocoumarin sensitive parY PROTEIN DIRECT_BINDING_TARGET

ARO:3003253

CARD/ARO database assertion; target organism, strain, and assay are not specified. ParY is asserted as the aminocoumarin-sensitive subunit. Evidence status: PRIMARY_EVIDENCE_NEEDED. Source: CARD_ARO 2026-08-30 (retrieved 2026-08-30).

aminocoumarin sensitive gyrB PROTEIN DIRECT_BINDING_TARGET

ARO:3003260

CARD/ARO database assertion; target organism, strain, and assay are not specified. GyrB is asserted as the aminocoumarin-sensitive subunit. Evidence status: PRIMARY_EVIDENCE_NEEDED. Source: CARD_ARO 2026-08-30 (retrieved 2026-08-30).

Mechanism summary

Mode of action
NUCLEIC_ACID_SYNTHESIS_INHIBITION host shared target — Assigned from ChEBI role CHEBI:50750 (EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor). ChEBI asserts the role on the compound. The target it names is one the host has too, so the mechanism is true but is not evidence of selectivity — see mode_of_action_target_scope. Not a curator's mechanistic review.

Resistance mechanisms

14 known routes by which microbes resist this compound, grounded in ARO where CARD models them. Grouped by mechanism type — expand a group to see its determinants.

ANTIBIOTIC_EFFLUX 7
ANTIBIOTIC_EFFLUX
DeterminantARO IDOrganismGene familiesEvidence
LptD ARO:3005059 not organism-specific
  • ARO:3005059 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000111 (novobiocin); database assertion, not a primary citation.)
MdtABC-TolC ARO:3000787 not organism-specific
  • ARO:3000787 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000111 (novobiocin); database assertion, not a primary citation.)
MexAB-OprM ARO:3000386 not organism-specific
  • ARO:3000386 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000111 (novobiocin); database assertion, not a primary citation.)
MexCD-OprJ ARO:3000797 not organism-specific
  • ARO:3000797 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000111 (novobiocin); database assertion, not a primary citation.)
MuxABC-OpmB ARO:3004076 not organism-specific
  • ARO:3004076 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000111 (novobiocin); database assertion, not a primary citation.)
abeS ARO:3000768 not organism-specific
  • ARO:3000768 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000111 (novobiocin); database assertion, not a primary citation.)
novA ARO:3002522 not organism-specific
  • ARO:3002522 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000111 (novobiocin); database assertion, not a primary citation.)
ANTIBIOTIC_TARGET_ALTERATION 7
ANTIBIOTIC_TARGET_ALTERATION
DeterminantARO IDOrganismGene familiesEvidence
Bartonella bacilliformis gyrB conferring resistance to aminocoumarin ARO:3003302 not organism-specific
  • ARO:3003302 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000111 (novobiocin); database assertion, not a primary citation.)
Escherichia coli gyrB conferring resistance to aminocoumarin ARO:3003303 not organism-specific
  • ARO:3003303 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000111 (novobiocin); database assertion, not a primary citation.)
Staphylococcus aureus gyrB conferring resistance to aminocoumarin ARO:3003301 not organism-specific
  • ARO:3003301 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000111 (novobiocin); database assertion, not a primary citation.)
Staphylococcus aureus parE conferring resistance to aminocoumarin ARO:3003314 not organism-specific
  • ARO:3003314 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000111 (novobiocin); database assertion, not a primary citation.)
Streptomyces rishiriensis parY mutant conferring resistance to aminocoumarin ARO:3003318 not organism-specific
  • ARO:3003318 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000111 (novobiocin); database assertion, not a primary citation.)
aminocoumarin-resistant alaS ARO:3003830 not organism-specific
  • ARO:3003830 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000111 (novobiocin); database assertion, not a primary citation.)
aminocoumarin-resistant cysB ARO:3003840 not organism-specific
  • ARO:3003840 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000111 (novobiocin); database assertion, not a primary citation.)

Causal graphs

Evidence-backed mechanism graphs: how the compound reaches its target, what the target does, and how the effect propagates to growth inhibition or death.

Novobiocin inhibits GyrB ATPase-dependent DNA supercoiling MECHANISTIC

Novobiocin binds the amino-terminal coumarin-binding region of bacterial DNA gyrase subunit GyrB, competitively inhibits its ATPase activity, and blocks ATP-dependent DNA supercoiling by gyrase.

Nodes — novobiocin_gyrb_atpase_inhibition
NodeLabelTypeGrounding
novobiocin novobiocin COMPOUND CHEBI:28368
gyrb bacterial DNA gyrase subunit GyrB GENE_OR_PROTEIN ARO:3000734
gyrb_coumarin_binding_domain GyrB amino-terminal coumarin-binding domain STATE REVIEWED_LABEL_ONLY
gyrb_atpase_activity GyrB ATPase activity MOLECULAR_FUNCTION REVIEWED_LABEL_ONLY
dna_supercoiling ATP-dependent DNA supercoiling BIOLOGICAL_PROCESS REVIEWED_LABEL_ONLY
dna_topology_control bacterial DNA topology control BIOLOGICAL_PROCESS REVIEWED_LABEL_ONLY
Edges — novobiocin_gyrb_atpase_inhibition
SubjectPredicateObjectEvidence
novobiocin binds gyrb_coumarin_binding_domain
  • PMID:8065258 (Gilbert and Maxwell mapped coumarin-drug binding to a 24 kDa N-terminal GyrB subdomain.)
gyrb contains gyrb_coumarin_binding_domain
  • PMID:8065258 (The GyrB 24 kDa amino-terminal fragment retained coumarin-drug binding.)
gyrb enables gyrb_atpase_activity
  • PMID:6269086 (Purified GyrB carried the ATPase activity inhibited competitively by novobiocin and related coumarins.)
novobiocin inhibits gyrb_atpase_activity
  • PMID:6269086 (The affinity-purified GyrB study characterized novobiocin as a competitive inhibitor of GyrB ATPase activity.)
gyrb_atpase_activity supports dna_supercoiling
  • PMID:794878 (Gellert and colleagues showed novobiocin inhibits ATP-dependent DNA supercoiling catalyzed by purified DNA gyrase.)
dna_supercoiling supports dna_topology_control
  • PMID:794878 (The purified gyrase assays connect GyrB ATPase inhibition to loss of DNA supercoiling.)

Curation history

  1. SEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Seeded from data/raw/ inventories (ARO, CHEBI)

  2. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  3. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  4. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  5. CURATED_CAUSAL_GRAPH 2026-09-04 · codex · LLM-assisted

    Added a PMID-supported causal graph for novobiocin inhibition of GyrB ATPase-dependent DNA supercoiling.

Provenance

Seeded by scripts/seed_from_sources.py from the committed inventories in data/raw/. View the record.